Discontinuation of Antiviral Therapy as a Strategy to Cure Hepatitis B

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2026

Conditions

Hepatitis B, Chronic

Interventions

OTHER

Stopping

Discontinuation of nucleoside analogue

Trial Locations (1)

Infectious Diseases Clinic, Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors

collaborator

Sahlgrenska University Hospital

OTHER

lead

Göteborg University

OTHER